SeaStar Medical Holding Corporation (NASDAQ:ICU) — Market Cap & Net Worth
Market Cap & Net Worth: SeaStar Medical Holding Corporation (ICU)
SeaStar Medical Holding Corporation (NASDAQ:ICU) has a market capitalization of $12.67 Million ($12.67 Million) as of September 18, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #26540 globally and #5532 in its home market, demonstrating a 12.81% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying SeaStar Medical Holding Corporation's stock price $3.50 by its total outstanding shares 3997002 (4.00 Million). Also see ICU asset base for a full breakdown of the balance sheet.
SeaStar Medical Holding Corporation Market Cap History: 2021 to 2026
SeaStar Medical Holding Corporation's market capitalization history from 2021 to 2026. Data shows change from $1.00 Billion to $13.98 Million (-53.79% CAGR). Also see cash efficiency ratio of SeaStar Medical Holding Corporation for how efficiently the company converts equity into cash flow.
Index Memberships
SeaStar Medical Holding Corporation is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.67 Trillion | 0.00% | #747 of 976 |
|
NASDAQ Composite
IXIC
|
$41.95 Trillion | 0.00% | #2445 of 3165 |
Weight: SeaStar Medical Holding Corporation's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
SeaStar Medical Holding Corporation Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how SeaStar Medical Holding Corporation's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check ICU stock price for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
0.78x
SeaStar Medical Holding Corporation's market cap is 0.78 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2024 | $7.75 Million | $135.00K | -$24.83 Million | 57.44x | N/A |
| 2025 | $959.28K | $1.23 Million | -$12.15 Million | 0.78x | N/A |
Competitor Companies of ICU by Market Capitalization
Companies near SeaStar Medical Holding Corporation in the global market cap rankings as of September 18, 2026. Review tangible net worth ratio of SeaStar Medical Holding Corporation to assess the quality of the company's equity after excluding intangible assets.
Key companies related to SeaStar Medical Holding Corporation by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #185 globally with a market cap of $130.87 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #337 globally with a market cap of $79.84 Billion USD.
- CSL Ltd (AU:CSL): Ranked #455 globally with a market cap of $60.95 Billion USD ( AU$86.14 Billion AUD).
- Moderna Inc (NASDAQ:MRNA): Ranked #504 globally with a market cap of $54.14 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #185 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $130.87 Billion | $516.34 |
| #337 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $79.84 Billion | $789.45 |
| #455 | CSL Ltd | AU:CSL | $60.95 Billion | AU$177.56 |
| #504 | Moderna Inc | NASDAQ:MRNA | $54.14 Billion | $158.07 |
SeaStar Medical Holding Corporation Historical Marketcap From 2021 to 2026
Between 2021 and today, SeaStar Medical Holding Corporation's market cap moved from $1.00 Billion to $ 13.98 Million, with a yearly change of -53.79%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $13.98 Million | +1357.17% |
| 2025 | $959.28K | -87.63% |
| 2024 | $7.75 Million | -82.48% |
| 2023 | $44.27 Million | -89.20% |
| 2022 | $409.69 Million | -59.16% |
| 2021 | $1.00 Billion | -- |
End of Day Market Cap According to Different Sources
On Sep 18th, 2026 the market cap of SeaStar Medical Holding Corporation was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $12.67 Million USD |
| MoneyControl | $12.67 Million USD |
| MarketWatch | $12.67 Million USD |
| marketcap.company | $12.67 Million USD |
| Reuters | $12.67 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About SeaStar Medical Holding Corporation
SeaStar Medical Holding Corporation, a commercial-stage healthcare company, develops a proprietary platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers the selective cytopheretic device (SCD), which is a disease-modifying device that neutralizes over-active immune cells and stops the cytokine storm that yields destructive hyperi… Read more